IMS Health to Share Marketing and Sales Effectiveness Insights at 2003 PMC
IMS Exhibit Showcases Offerings That Maximize Brand Performance and Sales Force Effectiveness
IMS Public Relations
PHILADELPHIA, PA, Pharmaceutical Marketing Congress, Sept. 29, 2003 – IMS Health, the world’s leading provider of information and consulting solutions for the pharmaceutical industry, is poised to boost pharmaceutical companies’ business results with an array of new and enhanced products, solutions and consulting services that provide fresh insights based on longitudinal and behavioral data.
Attendees at this year’s Congress will learn more about these capabilities as IMS leads a workshop on Integrated Segmentationsm and a plenary session detailing an Integrated Segmentationsm case study. In addition, IMS will present several new and highly focused offerings that address two of pharmaceutical marketing executives’ most pressing concerns—maximizing brand performance and sales force effectiveness.
Leveraging a nearly 50-year track record and a product and services portfolio that is unsurpassed in the pharmaceuticals information market, IMS is focused on those key commercial business processes that are critical to all pharmaceutical companies’ success—Brand Management, Launch Management, Sales Force Effectiveness, Portfolio Optimization and Managed Care.
As an executive sponsor of this year’s Congress, our goal is to help pharmaceutical companies succeed by marketing and selling to the right physicians, with the right frequency, and the right message, using the most effective communications channels, ” said Bruce Boggs, IMS senior vice president, Marketing, Americas. “At IMS, we are investing heavily in helping our clients achieve and sustain market leadership and long-term growth.”
Opening day features an IMS workshop, “Integrated Segmentationsm: Improving ROI by Aligning Sales and Marketing Efforts with Customer Needs,” (9:30 A.M. Monday, September 29). This is followed on Day 3 with a plenary session featuring a case study, “Using Integrated Segmentationsm to Maximize Sales Force Effectiveness,” (1:15 P.M. Wednesday, October 1). The company will also feature two new offerings, IMS NPAÔ Market DynamicsÔ and IMS Precision SegmentationÔ at booth #27, where representatives will be on hand to discuss the company’s broad portfolio of business solutions and consulting services.
For more information on the IMS-sponsored events at PMC and to learn more about the broad array of IMS business solutions and consulting services, visit www.imshealth.com.
About IMS Health
Operating in more than 100 countries, IMS is the world’s leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.4 billion in 2002 revenue and nearly 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients’ day-to-day operations, including marketing effectiveness solutions for prescription and over-the-counter pharmaceutical products; sales optimization solutions to increase pharmaceutical sales force productivity; and consulting and customized services that turn information into actionable insights. Additional information is available at www.imshealth.com.